Impact of Tumor Characteristic on the Outcome of Liver Transplantation in Patients With Hepatocellular Carcinoma

被引:30
|
作者
Dudek, K.
Kornasiewicz, O.
Remiszewski, P.
Kobryn, K. [1 ]
Ziarkiewicz-Wroblewska, B. [2 ]
Gornicka, B. [2 ]
Zieniewicz, K.
Krawczyk, M.
机构
[1] Med Univ Warsaw 1A, Dept Gen Transplant & Liver Surg, Students Sci Grp, Warsaw, Poland
[2] Med Univ Warsaw 1A, Dept Pathol, Warsaw, Poland
关键词
PREDICTING RECURRENCE; DIFFERENTIATION; RESECTION; SURVIVAL; INVASION; HCC;
D O I
10.1016/j.transproceed.2009.08.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction. Orthotopic liver transplantation (OLT) is a well-established treatment for cirrhotic patients with hepatocellular carcinoma (HCC) who meet the Milan criteria. The aim of this study was to identify predictors of survival among 65 patients with HCC in cirrhotic livers who underwent liver transplantation (OLT). Methods. From January 2001 to December 2008, we performed 655 OLT in 615 patients. HCC was diagnosed in 58 patients before OLT and in 65 by histological examination of the explanted livers; 74% of the patients met Milan criteria by histological examination. Results. The median follow-up was 27 months (range = 1-96). We analyzed patient age and gender, etiology of liver disease, Child score at transplantation, rejection episodes, tumor number/size, vascular invasion, and differentiation grade. There was no significant difference in survival among patients grouped according to the Model for End-stage Liver Disease staging system for HCC. The 5-year survival of patients with low differentiated (G3) HCC was significantly worse than that of those with moderately differentiated (G2) or well-differentiated (G1) HCC: 50%, 81%, and 86% respectively, (P < .01). Patients with microvascular invasion displayed a worse 5-year survival than those without vascular invasion (42% vs 80%; P < .01). Conclusions. The analysis indicated that the histological grade of the tumors and evidences of microscopic vascular invasion were the most useful predictive factors for overall survival among patients with cirrhosis after liver transplantation for HCC.
引用
收藏
页码:3135 / 3137
页数:3
相关论文
共 50 条
  • [41] Predictors of Outcome in Patients with Hepatocellular Carcinoma (HCC) Treated with Liver Transplantation.
    AkhavanHeidari, M.
    Akoad, M.
    Wagener, M.
    Karuman, P.
    Cacciarelli, T. V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 469 - 469
  • [42] Outcome of 1723 Hepatocellular Carcinoma Patients Undergoing Liver Transplantation: Tianjin Experience
    Shen Zhongyang
    Zhu Zhijun
    Zheng Hong
    Deng Yonglin
    Pan Cheng
    LIVER TRANSPLANTATION, 2011, 17 (06) : S215 - S215
  • [43] Impact of Graft Type on the Survival Outcome of Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma
    Chan, Albert
    Chan, See Ching
    Chok, Kenneth
    Cheung, Tan To
    Lo, Chung Mau
    LIVER TRANSPLANTATION, 2014, 20 : S360 - S360
  • [44] Impact of female gender on longterm outcome after liver transplantation for Hepatocellular Carcinoma (HCC)
    Saliba, F.
    El Domiaty, N.
    Pascale, A.
    Coilly, A.
    Sobesky, R.
    Ibrahim, W.
    Pittau, G.
    Ciacio, O.
    Salloum, C.
    De Martin, E.
    Cunha, A. Sa
    Golse, N.
    Allard, M. A.
    Azoulay, D.
    Vibert, E.
    Adam, R.
    Samuel, D.
    Rosemorduc, O.
    Cherqui, D.
    LIVER TRANSPLANTATION, 2024, 30 : 239 - 239
  • [45] Do Preoperative Inflammatory Markers Impact on Outcome After Liver Transplantation for Hepatocellular Carcinoma?
    Sapisochin, Gonzalo
    Yao, Francis Y.
    Roberts, John P.
    ANNALS OF SURGERY, 2011, 254 (02) : 383 - 383
  • [46] Liver transplantation after tumor downstaging in hepatocellular carcinoma
    Fritsch, Johannes
    Ardelt, Michael
    Settmacher, Utz
    CHIRURG, 2020, 91 (10): : 891 - 891
  • [47] Hepatocellular Carcinoma and Total Tumor Volume in Liver Transplantation
    Philip, Sunu
    Mahadevappa, Basant
    Rudnick, Melanie
    Shaish, Hiram
    Jain, Shilpa
    Bentley-Hibbert, Stuart
    Rochon, Caroline
    Gunasekaran, Ganesh
    LIVER TRANSPLANTATION, 2012, 18 : S280 - S280
  • [48] LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: INCIDENTAL VERSUS NO TUMOR
    Ringe, Burckhardt
    Xiao, Gary
    Sass, David
    Shang, Sherry
    Maroney, Timothy
    Trebelev, Alexander
    Reich, David
    Rothstein, Kenneth
    LIVER TRANSPLANTATION, 2009, 15 (07) : S254 - S254
  • [49] Changes in Tumor Markers and Their Implications in Selecting Liver Transplantation for Patients With Hepatocellular Carcinoma
    Song, Byeong Geun
    Sinn, Dong Hyun
    Kang, Wonseok
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    Kim, Jong Man
    Joh, Jae-Won
    Choi, Gyu-Seong
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (03) : 881 - 888
  • [50] Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria
    Amado, Victor
    Rodriguez-Peralvarez, Manuel
    Ferrin, Gustavo
    De la Mata, Manuel
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2019, 6 : 1 - 10